for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

McKesson Corporation

MCK.N

Latest Trade

147.71USD

Change

-11.27(-7.09%)

Volume

1,602,258

Today's Range

147.67

 - 

157.07

52 Week Range

110.63

 - 

172.15

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
158.98
Open
155.51
Volume
1,602,258
3M AVG Volume
37.23
Today's High
157.07
Today's Low
147.67
52 Week High
172.15
52 Week Low
110.63
Shares Out (MIL)
180.19
Market Cap (MIL)
28,459.26
Forward P/E
--
Dividend (Yield %)
1.02

Next Event

Dividend For MCK.N - 0.4100 USD

Latest Developments

More

Mckesson - In Jan. 2020, U.S. Attorney’S Office For District Of Massachusetts Served Civil Investigative Demand On Co Seeking Documents

Mckesson Reports Q3 Adjusted Earnings Per Share $3.81

Lightship Appoints David Macmurchy As CEO

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About McKesson Corporation

McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare. It operates through two segments: McKesson Distribution Solutions and McKesson Technology Solutions. The distribution solutions segment distributes branded and generic pharmaceutical drugs and other healthcare-related products internationally and provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. Technology Solutions segment provides software and analytics, network solutions and technology-enabled services.

Contact Info

6555 State Highway 161

+1.972.4464800

http://www.mckesson.com

Executive Leadership

Edward A. Mueller

Independent Chairman of the Board

Brian Scott Tyler

Chief Executive Officer, Director

Britt J. Vitalone

Chief Financial Officer, Executive Vice President

Tracy Faber

Chief Human Resource Officer, Executive Vice President

Nancy Flores

Executive Vice President, Chief Technology Officer, Chief Information Officer

Key Stats

2.42 mean rating - 19 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

198.5K

2018

208.4K

2019

214.3K

2020(E)

228.3K
EPS (USD)

2017

12.910

2018

12.620

2019

13.570

2020(E)

14.765
Price To Earnings (TTM)
--
Price To Sales (TTM)
0.13
Price To Book (MRQ)
4.61
Price To Cash Flow (TTM)
176.77
Total Debt To Equity (MRQ)
159.54
LT Debt To Equity (MRQ)
109.07
Return on Investment (TTM)
-3.71
Return on Equity (TTM)
-1.26

Latest News

Latest News

BRIEF-McKesson, Opioid Distributors Propose $1 Billion Legal Fee Fund - Bloomberg News

* MCKESSON, OPIOID DISTRIBUTORS PROPOSE $1 BILLION LEGAL FEE FUND - BLOOMBERG NEWS Source text - https://bloom.bg/32dcGZY Further company coverage:

BRIEF-Mckesson Launches Exchange Offer To Split-Off Its Interest In Change Healthcare

* MCKESSON LAUNCHES EXCHANGE OFFER TO SPLIT-OFF ITS INTEREST IN CHANGE HEALTHCARE

McKesson meets full-year profit estimates, renews partnership with CVS

U.S. drug distributor McKesson Corp forecast a full-year profit on Wednesday that matched analysts' estimates, easing some fears over drug pricing pressures and costs of opioid-related litigations.

Drug distributor McKesson posts smaller 4th-qtr loss

U.S. drug distributor McKesson Corp reported a smaller fourth-quarter loss on Wednesday, as its surgical distribution business was boosted by the company's recent acquisition of Medical Specialties Distributors LLC.

McKesson to pay $37 million to resolve West Virginia opioid lawsuit

Drug distributor McKesson Corp has agreed to pay $37 million to resolve a lawsuit by the state of West Virginia seeking to hold it responsible for contributing to the opioid epidemic, the state's attorney general said on Thursday.

McKesson to pay $37 million to resolve West Virginia opioid lawsuit

Drug distributor McKesson Corp has agreed to pay $37 million to resolve a lawsuit by the state of West Virginia seeking to hold it responsible for contributing to the opioid epidemic, the state's attorney general said on Thursday.

McKesson's Change Healthcare hires IPO underwriters: sources

Change Healthcare LLC, a healthcare technology company majority-owned by U.S. drug wholesaler McKesson Corp <MCK.N>, has hired underwriters for an initial public offering that could value it at as much as $12 billion, including debt, people familiar with the matter said...

BRIEF-McKesson Board Of Directors Elects Brad Lerman As New Independent Director

* MCKESSON BOARD OF DIRECTORS ELECTS BRAD LERMAN AS NEW INDEPENDENT DIRECTOR

BRIEF-McKesson Launches Multi-Year Strategic Growth Initiative; Reaffirms Fiscal 2018 Outlook

* MCKESSON LAUNCHES MULTI-YEAR STRATEGIC GROWTH INITIATIVE; REAFFIRMS FISCAL 2018 OUTLOOK AND PROVIDES PRELIMINARY FISCAL 2019 OUTLOOK

BRIEF-Polarityte Announces Appointment Of Mckesson’S Willie Bogan To Board Of Directors

* POLARITYTE ANNOUNCES APPOINTMENT OF MCKESSON’S WILLIE BOGAN TO BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

BRIEF-McKesson Corp Files Preliminary Prospectus Supplement Related To A Potential Two-Part Note Offering

* MCKESSON CORP FILES PRELIMINARY PROSPECTUS SUPPLEMENT RELATED TO A POTENTIAL TWO-PART NOTE OFFERING OF UP TO EUR 750 MILLION - SEC FILING Source text : (http://bit.ly/2H0ogwC) Further company coverage:

BRIEF-McKesson Corp Files Preliminary Prospectus Supplement Related To A Potential Notes Due 2028

* MCKESSON CORP FILES PRELIMINARY PROSPECTUS SUPPLEMENT RELATED TO A POTENTIAL NOTES DUE 2028 OFFERING OF UP TO $600 MILLION - SEC FILING Source text : (http://bit.ly/2G22iIb) Further company coverage:

BRIEF-Mckesson Files Preliminary Prospectus Supplement Related To Potential Offering Of Notes

* MCKESSON CORP FILES PRELIMINARY PROSPECTUS SUPPLEMENT RELATED TO A POTENTIAL OFFERING OF NOTES DUE 2020 - SEC FILING Source text - http://bit.ly/2FUEDJW Further company coverage:

UPDATE 3-McKesson says drug prices competitive but not volatile like 2017

* Books tax benefit of $370 mln in 3rd quarter (Adds company commentary on generic drug prices, background, analyst quotes; updates stock prices)

CORRECTED-UPDATE 1-Drug distributor McKesson's quarterly profit beats estimates

McKesson Corp posted a better-than-expected quarterly profit, as the biggest U.S. drug distributor continues to benefit from its tie-up with Walmart .

BRIEF-McKesson Reports Q3 Adjusted Earnings Per Share $3.41

* Q3 GAAP EARNINGS PER SHARE $4.32 FROM CONTINUING OPERATIONS

Drug distributor McKesson posts 42.6 pct rise in quarterly profit

McKesson Corp, the biggest U.S. drug distributor, reported a 42.6 percent rise in quarterly profit on Thursday, partly helped by a $370 million tax benefit related to changes to U.S. tax laws.

Kentucky accuses McKesson of helping fuel opioid epidemic

Kentucky's attorney general on Monday accused drug distributor McKesson Corp of helping fuel the opioid epidemic by failing to halt shipments of suspiciously large or frequent orders by pharmacies of prescription painkillers.

BRIEF-Mckesson Corp Says Co's Committee Approved An Annual Base Salary Of $750,000 For CFO

* MCKESSON CORP SAYS ON JAN 4, CO'S COMPENSATION COMMITTEE APPROVED AN ANNUAL BASE SALARY OF $750,000 FOR CFO BRITT VITALONE - SEC FILING Source text for Eikon: (http://bit.ly/2qQlDK1) Further company coverage:

BRIEF-Mckesson Announces Departure Of James Beer, EVP And CFO

* MCKESSON ANNOUNCES DEPARTURE OF JAMES BEER, EVP AND CFO; APPOINTS INTERNAL SUCCESSOR, BRITT VITALONE; REAFFIRMS FISCAL 2018 OUTLOOK

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up